Gustavo A. Rosario Benitez

Array ( [id] => 9778160 [patent_doc_number] => 08853368 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-10-07 [patent_title] => 'Human antibodies against human glycoprotein VI and their use' [patent_app_type] => utility [patent_app_number] => 10/499266 [patent_app_country] => US [patent_app_date] => 2002-12-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 30 [patent_no_of_words] => 23122 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 10499266 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 432438 [patent_doc_number] => 07265212 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-09-04 [patent_title] => 'Anti-CD45RB antibodies' [patent_app_type] => utility [patent_app_number] => 10/309764 [patent_app_country] => US [patent_app_date] => 2002-12-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 41 [patent_figures_cnt] => 73 [patent_no_of_words] => 19113 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 83 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/265/07265212.pdf [firstpage_image] =>[orig_patent_app_number] => 10309764 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6739704 [patent_doc_number] => 20030157073 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-08-21 [patent_title] => 'Methods for pretreating a subject with apoptotic cells' [patent_app_type] => new [patent_app_number] => 10/306786 [patent_app_country] => US [patent_app_date] => 2002-11-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 56430 [patent_no_of_claims] => 212 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0157/20030157073.pdf [firstpage_image] =>[orig_patent_app_number] => 10306786 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6984122 [patent_doc_number] => 20050154192 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-07-14 [patent_title] => 'Anti-il13 receptor alpha1 neutralizing antibody' [patent_app_type] => utility [patent_app_number] => 10/496869 [patent_app_country] => US [patent_app_date] => 2002-11-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 18715 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0154/20050154192.pdf [firstpage_image] =>[orig_patent_app_number] => 10496869 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6678170 [patent_doc_number] => 20030228310 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-12-11 [patent_title] => 'Treatment of skin diseases' [patent_app_type] => new [patent_app_number] => 10/304802 [patent_app_country] => US [patent_app_date] => 2002-11-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24270 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0228/20030228310.pdf [firstpage_image] =>[orig_patent_app_number] => 10304802 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6701115 [patent_doc_number] => 20030223995 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-12-04 [patent_title] => 'Treatment of pemphigus vulgaris' [patent_app_type] => new [patent_app_number] => 10/305210 [patent_app_country] => US [patent_app_date] => 2002-11-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22456 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0223/20030223995.pdf [firstpage_image] =>[orig_patent_app_number] => 10305210 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 314533 [patent_doc_number] => 07524502 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-04-28 [patent_title] => 'Modified anti-TNF alpha antibody' [patent_app_type] => utility [patent_app_number] => 10/495146 [patent_app_country] => US [patent_app_date] => 2002-11-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 11 [patent_no_of_words] => 14753 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 129 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/524/07524502.pdf [firstpage_image] =>[orig_patent_app_number] => 10495146 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 448086 [patent_doc_number] => 07250167 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-07-31 [patent_title] => 'Method of treatment with anti-CD2 antibody LO-CD2b' [patent_app_type] => utility [patent_app_number] => 10/288977 [patent_app_country] => US [patent_app_date] => 2002-11-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 14 [patent_no_of_words] => 15767 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/250/07250167.pdf [firstpage_image] =>[orig_patent_app_number] => 10288977 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6971294 [patent_doc_number] => 20050037004 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-02-17 [patent_title] => 'Treatment of chronic joint inflammation' [patent_app_type] => utility [patent_app_number] => 10/491112 [patent_app_country] => US [patent_app_date] => 2002-09-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6645 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0037/20050037004.pdf [firstpage_image] =>[orig_patent_app_number] => 10491112 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6869491 [patent_doc_number] => 20030082180 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-05-01 [patent_title] => 'Combination of compounds that inhibit the biological effects of tnf-alpha and cd95l in a medicament' [patent_app_type] => new [patent_app_number] => 10/149335 [patent_app_country] => US [patent_app_date] => 2002-09-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 6180 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0082/20030082180.pdf [firstpage_image] =>[orig_patent_app_number] => 10149335 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7126904 [patent_doc_number] => 20050058648 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-17 [patent_title] => 'Antibodies against caspase-8, their preparation and use' [patent_app_type] => utility [patent_app_number] => 10/488608 [patent_app_country] => US [patent_app_date] => 2002-09-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 16140 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0058/20050058648.pdf [firstpage_image] =>[orig_patent_app_number] => 10488608 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7457058 [patent_doc_number] => 20040197329 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-10-07 [patent_title] => 'Remedies or preventives for rheumatoid arthritis' [patent_app_type] => new [patent_app_number] => 10/204228 [patent_app_country] => US [patent_app_date] => 2002-08-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 14376 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0197/20040197329.pdf [firstpage_image] =>[orig_patent_app_number] => 10204228 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7965387 [patent_doc_number] => 07939295 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-05-10 [patent_title] => 'Methods for reducing immunogenicity of polypeptides' [patent_app_type] => utility [patent_app_number] => 10/483153 [patent_app_country] => US [patent_app_date] => 2002-07-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10599 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 168 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/939/07939295.pdf [firstpage_image] =>[orig_patent_app_number] => 10483153 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4564680 [patent_doc_number] => 07858095 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-12-28 [patent_title] => 'Method for treating or preventing sclerotic disorders using CD-2 binding agents' [patent_app_type] => utility [patent_app_number] => 10/484329 [patent_app_country] => US [patent_app_date] => 2002-07-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25785 [patent_no_of_claims] => 49 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 82 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/858/07858095.pdf [firstpage_image] =>[orig_patent_app_number] => 10484329 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10863446 [patent_doc_number] => 08889135 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-11-18 [patent_title] => 'Methods of administering anti-TNFα antibodies' [patent_app_type] => utility [patent_app_number] => 10/163657 [patent_app_country] => US [patent_app_date] => 2002-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 17268 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 150 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 10163657 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4860263 [patent_doc_number] => 20080269113 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-30 [patent_title] => 'P53 BINDING T CELL RECEPTOR MOLECULES' [patent_app_type] => utility [patent_app_number] => 10/163084 [patent_app_country] => US [patent_app_date] => 2002-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 13762 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0269/20080269113.pdf [firstpage_image] =>[orig_patent_app_number] => 10163084 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6735151 [patent_doc_number] => 20030012786 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-01-16 [patent_title] => 'Use of anti-TNF antibodies as drugs in treating septic disorders of anemic patients' [patent_app_type] => new [patent_app_number] => 10/154025 [patent_app_country] => US [patent_app_date] => 2002-05-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1623 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0012/20030012786.pdf [firstpage_image] =>[orig_patent_app_number] => 10154025 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6869467 [patent_doc_number] => 20030082156 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-05-01 [patent_title] => 'Polypeptides and methods for thymic vaccination' [patent_app_type] => new [patent_app_number] => 10/155879 [patent_app_country] => US [patent_app_date] => 2002-05-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 18464 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0082/20030082156.pdf [firstpage_image] =>[orig_patent_app_number] => 10155879 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4619207 [patent_doc_number] => 07998926 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-08-16 [patent_title] => 'Dimerized T-cell receptor fragment, its compositions and use' [patent_app_type] => utility [patent_app_number] => 10/478194 [patent_app_country] => US [patent_app_date] => 2002-05-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 9349 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 407 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/998/07998926.pdf [firstpage_image] =>[orig_patent_app_number] => 10478194 [rel_patent_id] =>[rel_patent_doc_number] =>)